Hot Marketing Opps

It is fair to say that, economically, a pharmaceutical company’s bottom line requires it to sell products competitively, but a larger viewer should also be taken. The company occupies a key position, from a marketing perspective, between the government and other regulators and ultimately the patient. There is a complex understanding and relationship between all the main players and pharmaceutical consultants help to emphasise these individual roles, as they disseminate information to help oil all the moving parts of this complex machine.

FDA regulations require pharmaceutical companies to be in strict compliance, make use of established practices and all safety criteria as they produce products for final use. The importance of marketing in this environment should never be underestimated. The physician or pharmacist has to juggle a lot of information, much of it based on older science, together with the wants and needs of the patient and budgetary restrictions applied by insurance companies or individual positions.

If the patient is to be adequately catered to, it is important that lines of communication between pharmaceutical companies and professionals are open and clear and this is where marketing is so important. It follows that the standard of this marketing and its effectiveness directly contributes to the patient’s ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. The company must not only communicate the benefits and risks of its product to the professional, the reasoning and science behind its introduction and instructions for its use, but the professional must give real world feedback and crucial data to the company.

The fact that pharma consulting can provide cutting-edge information about conditions and treatments, spotlighting certain illnesses which may not have received much attention, should not be underestimated. We still have many conditions without a cure and pharmaceutical company research can often go a long way to bridging that gap, if not even enabling cutting-edge treatment for patients. There is no guarantee that such amazing products may even find their way into the hands of the sufferer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

As more and more information is revealed through scientific study, product creation and government rubber-stamping, more of a spotlight is turned on the need for treatment of chronic diseases. As such, any by-products or side effects of new solutions may not become known, nor the link between cure and original illness exposed, unless strong marketing channels are open between all concerned.

In most instances, pharmaceutical consulting firms can also play a critical role in educating clients, producers and users. Their experience, knowledge and enthusiasm can really help to turn the wheels of the marketing machine, continuously engaging all key players and producing incredible results in such a competitive environment.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.